Literature DB >> 19890261

Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.

Barbara Franke1, Alejandro Arias Vasquez, Stefan Johansson, Martine Hoogman, Jasmin Romanos, Andrea Boreatti-Hümmer, Monika Heine, Christian P Jacob, Klaus-Peter Lesch, Miguel Casas, Marta Ribasés, Rosa Bosch, Cristina Sánchez-Mora, Núria Gómez-Barros, Noèlia Fernàndez-Castillo, Mònica Bayés, Anne Halmøy, Helene Halleland, Elisabeth T Landaas, Ole B Fasmer, Per M Knappskog, Angelien J G A M Heister, Lambertus A Kiemeney, J J Sandra Kooij, A Marije Boonstra, Cees C Kan, Philip Asherson, Stephen V Faraone, Jan K Buitelaar, Jan Haavik, Bru Cormand, Josep Antoni Ramos-Quiroga, Andreas Reif.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders with a worldwide prevalence around 4-5% in children and 1-4% in adults. Although ADHD is highly heritable and familial risk may contribute most strongly to the persistent form of the disorder, there are few studies on the genetics of ADHD in adults. In this paper, we present the first results of the International Multicentre Persistent ADHD Genetics CollaboraTion (IMpACT) that has been set up with the goal of performing research into the genetics of persistent ADHD. In this study, we carried out a combined analysis as well as a meta-analysis of the association of the SLC6A3/DAT1 gene with persistent ADHD in 1440 patients and 1769 controls from IMpACT and an earlier report. DAT1, encoding the dopamine transporter, is one of the most frequently studied genes in ADHD, though results have been inconsistent. A variable number tandem repeat polymorphism (VNTR) in the 3'-untranslated region (UTR) of the gene and, more recently, a haplotype of this VNTR with another VNTR in intron 8 have been the target of most studies. Although the 10/10 genotype of the 3'-UTR VNTR and the 10-6 haplotype of the two VNTRs are thought to be risk factors for ADHD in children, we found the 9/9 genotype and the 9-6 haplotype associated with persistent ADHD. In conclusion, a differential association of DAT1 with ADHD in children and in adults might help explain the inconsistencies observed in earlier association studies. However, the data might also imply that DAT1 has a modulatory rather than causative role in ADHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890261      PMCID: PMC3055604          DOI: 10.1038/npp.2009.170

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

1.  Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

Authors:  J J Sandra Kooij; Jan K Buitelaar; Edwin J van den Oord; Johan W Furer; Cees A Th Rijnders; Paul P G Hodiamont
Journal:  Psychol Med       Date:  2005-06       Impact factor: 7.723

Review 2.  The dopamine transporter and attention-deficit/hyperactivity disorder.

Authors:  Bertha K Madras; Gregory M Miller; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2005-01-05       Impact factor: 13.382

Review 3.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

4.  Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.

Authors:  Keeley J Brookes; Benjamin M Neale; Karen Sugden; Nadeem Khan; Philip Asherson; Ursula M D'Souza
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

5.  Gene-gene interaction associated with neural reward sensitivity.

Authors:  Juliana Yacubian; Tobias Sommer; Katrin Schroeder; Jan Gläscher; Raffael Kalisch; Boris Leuenberger; Dieter F Braus; Christian Büchel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

Review 6.  The consequences of attention-deficit/hyperactivity disorder in adults.

Authors:  David W Goodman
Journal:  J Psychiatr Pract       Date:  2007-09       Impact factor: 1.325

7.  Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics network.

Authors:  Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-08-15       Impact factor: 3.568

8.  Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis.

Authors:  Elias Zintzaras; Georgios M Hadjigeorgiou
Journal:  J Hum Genet       Date:  2004-08-04       Impact factor: 3.172

9.  Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD.

Authors:  Kaixin Zhou; Wai Chen; Jan Buitelaar; Tobias Banaschewski; Robert D Oades; Barbara Franke; Edmund Sonuga-Barke; Richard Ebstein; Jacques Eisenberg; Michael Gill; Iris Manor; Ana Miranda; Fernando Mulas; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Jessica Lasky-Su; Eric Taylor; Keeley J Brookes; Xiaohui Xu; Benjamin M Neale; Fruhling Rijsdijk; Margaret Thompson; Philip Asherson; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

10.  No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder.

Authors:  Daniel Brüggemann; Esther Sobanski; Barbara Alm; Thomas Schubert; Hannah Schmalzried; Alexandra Philipsen; Alexandra Phillipsen; Gerome Breen; Tim Becker; Alexander Georgi; Markus H Skowronek; Thomas G Schulze; Jens Treutlein; Marcella Rietschel
Journal:  Psychiatr Genet       Date:  2007-04       Impact factor: 2.458

View more
  75 in total

1.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

2.  DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders.

Authors:  Andreas Reif; T Trang Nguyen; Lena Weissflog; Christian P Jacob; Marcel Romanos; Tobias J Renner; Henriette N Buttenschon; Sarah Kittel-Schneider; Alexandra Gessner; Heike Weber; Maria Neuner; Silke Gross-Lesch; Karin Zamzow; Susanne Kreiker; Susanne Walitza; Jobst Meyer; Christine M Freitag; Rosa Bosch; Miquel Casas; Nuria Gómez; Marta Ribasès; Mónica Bayès; Jan K Buitelaar; Lambertus A L M Kiemeney; J J Sandra Kooij; Cees C Kan; Martine Hoogman; Stefan Johansson; Kaya K Jacobsen; Per M Knappskog; Ole B Fasmer; Phil Asherson; Andreas Warnke; Hans-Jörgen Grabe; Jessie Mahler; Alexander Teumer; Henry Völzke; Ole N Mors; Helmut Schäfer; Josep Antoni Ramos-Quiroga; Bru Cormand; Jan Haavik; Barbara Franke; Klaus-Peter Lesch
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

Review 3.  Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature.

Authors:  Michael M Plichta; Anouk Scheres
Journal:  Neurosci Biobehav Rev       Date:  2013-08-06       Impact factor: 8.989

4.  Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks.

Authors:  Ariel Beth Brown; Joseph Biederman; Eve Valera; Nikos Makris; Alysa Doyle; Susan Whitfield-Gabrieli; Eric Mick; Thomas Spencer; Stephen Faraone; Larry Seidman
Journal:  Psychiatry Res       Date:  2011-05-18       Impact factor: 3.222

5.  Predicting childhood effortful control from interactions between early parenting quality and children's dopamine transporter gene haplotypes.

Authors:  Yi Li; Michael J Sulik; Nancy Eisenberg; Tracy L Spinrad; Kathryn Lemery-Chalfant; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychopathol       Date:  2015-04-30

6.  Potential contribution of dopaminergic gene variants in ADHD core traits and co-morbidity: a study on eastern Indian probands.

Authors:  Subhamita Maitra; Kanyakumarika Sarkar; Paramita Ghosh; Arijit Karmakar; Animesh Bhattacharjee; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2014-03-02       Impact factor: 5.046

Review 7.  The attentive brain: insights from developmental cognitive neuroscience.

Authors:  Dima Amso; Gaia Scerif
Journal:  Nat Rev Neurosci       Date:  2015-10       Impact factor: 34.870

8.  Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark A Stein; Irwin Waldman; Jeffrey Newcorn; Jeffrey Bishop; Rick Kittles; Edwin H Cook
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

9.  Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Authors:  Andreas J Fallgatter; Ann-Christine Ehlis; Thomas Dresler; Andreas Reif; Christian P Jacob; Mauricio Arcos-Burgos; Maximilian Muenke; Klaus-Peter Lesch
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-12       Impact factor: 4.600

10.  Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD).

Authors:  Evangelia Stergiakouli; Anita Thapar
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.